Laboratory Corporation of America Holdings (NYSE:LH) — Market Cap & Net Worth
Market Cap & Net Worth: Laboratory Corporation of America Holdings (LH)
Laboratory Corporation of America Holdings (NYSE:LH) has a market capitalization of $21.71 Billion ($21.71 Billion) as of June 17, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1204 globally and #492 in its home market, demonstrating a 1.05% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laboratory Corporation of America Holdings's stock price $264.76 by its total outstanding shares 82000000 (82.00 Million). Review LH total liabilities to assess the company's total debt and financial obligations.
Laboratory Corporation of America Holdings Market Cap History: 2015 to 2026
Laboratory Corporation of America Holdings's market capitalization history from 2015 to 2026. Data shows growth from $8.41 Billion to $21.71 Billion (9.83% CAGR).
Index Memberships
Laboratory Corporation of America Holdings is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$62.23 Trillion | 0.04% | #352 of 503 |
Weight: Laboratory Corporation of America Holdings's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Laboratory Corporation of America Holdings Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Laboratory Corporation of America Holdings's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.47x
Laboratory Corporation of America Holdings's market cap is 1.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.47x
Laboratory Corporation of America Holdings's market cap is 23.47 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $8.74 Billion | $9.64 Billion | $732.10 Million | 0.91x | 11.93x |
| 2017 | $10.85 Billion | $10.44 Billion | $1.27 Billion | 1.04x | 8.56x |
| 2018 | $8.60 Billion | $11.33 Billion | $883.70 Million | 0.76x | 9.73x |
| 2019 | $11.51 Billion | $11.55 Billion | $823.80 Million | 1.00x | 13.97x |
| 2020 | $13.85 Billion | $13.98 Billion | $1.56 Billion | 0.99x | 8.90x |
| 2021 | $21.38 Billion | $13.14 Billion | $2.38 Billion | 1.63x | 8.99x |
| 2022 | $16.16 Billion | $11.86 Billion | $1.28 Billion | 1.36x | 12.63x |
| 2023 | $18.40 Billion | $12.16 Billion | $418.00 Million | 1.51x | 44.01x |
| 2024 | $18.80 Billion | $13.01 Billion | $746.00 Million | 1.45x | 25.21x |
| 2025 | $20.57 Billion | $13.95 Billion | $876.50 Million | 1.47x | 23.47x |
Competitor Companies of LH by Market Capitalization
Companies near Laboratory Corporation of America Holdings in the global market cap rankings as of June 17, 2026.
Key companies related to Laboratory Corporation of America Holdings by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Laboratory Corporation of America Holdings Historical Marketcap From 2015 to 2026
Between 2015 and today, Laboratory Corporation of America Holdings's market cap moved from $8.41 Billion to $ 21.71 Billion, with a yearly change of 9.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $21.71 Billion | +5.53% |
| 2025 | $20.57 Billion | +9.40% |
| 2024 | $18.80 Billion | +2.22% |
| 2023 | $18.40 Billion | +13.82% |
| 2022 | $16.16 Billion | -24.41% |
| 2021 | $21.38 Billion | +54.37% |
| 2020 | $13.85 Billion | +20.32% |
| 2019 | $11.51 Billion | +33.88% |
| 2018 | $8.60 Billion | -20.78% |
| 2017 | $10.85 Billion | +24.25% |
| 2016 | $8.74 Billion | +3.83% |
| 2015 | $8.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Laboratory Corporation of America Holdings was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.71 Billion USD |
| MoneyControl | $21.71 Billion USD |
| MarketWatch | $21.71 Billion USD |
| marketcap.company | $21.71 Billion USD |
| Reuters | $21.71 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcoh… Read more